Cahill Represents Lead Arrangers in $2.2 Billion Credit Facilities for ICU Medical’s Acquisition of Smiths Medical
Date: 01/06/22
Cahill represented the lead arrangers in connection with an $850,000,000 term A credit facility, an $850,000,000 term B credit facility and a $500,000,000 revolving credit facility for ICU Medical, Inc. Proceeds from the credit facility were used for the acquisition of the Smiths Medical business from Smiths Group plc, as well as for general corporate purposes and refinancing of existing indebtedness. ICU Medical develops, manufactures and sells medical technologies used in vascular therapy, oncology and critical care applications.